• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Four Controversial Diagnoses in Psychiatry: Are They Valid?
Clinical Update

Four Controversial Diagnoses in Psychiatry: Are They Valid?

March 8, 2023
Chris Aiken, MD and Tony Thrasher, DO, DFAPA
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Chris Aiken, MD. Editor-in-Chief of TCPR. Practicing psychiatrist. Winston-Salem, NC.

Tony Thrasher, DO, DFAPA. Immediate past president, American Association for Emergency Psychiatry (AAEP). Medical Director of Crisis Services, Milwaukee County Behavioral Health. Milwaukee, WI. Clinical Associate Professor, Medical College of Wisconsin. Milwaukee, WI.

Dr. Aiken and Dr. Thrasher have no financial relationships with companies related to this material.

Patients are increasingly diagnosing themselves with syndromes that are prominent on the internet but not noted in the DSM. You may have heard mention of sensory processing disorder, slow cognitive speed, or “ring of fire” ADHD, but how valid are these constructs?

Concepts of psychiatric diagnoses have varied by time and culture, but our current age is perhaps most influenced by an idea put forth by John Feighner and his neo-Kraepelinian colleagues in 1972 (Feighner JP et al, Arch Gen Psychiatry 1972;26(1):57–63). They called for five validators of psychiatric diagnoses: clinical description, laboratory studies, delineation from other disorders, course of illness, and family studies. Most psychiatric disorders fall short in the laboratory category, so a different biological marker was later suggested in its place: treatment response.

Feighner’s paper influenced the transition from DSM-II to DSM-III, although many disorders that are recognized in DSM-5 do not meet his strict criteria. Still, his paper provides a useful framework to evaluate these newer concepts.

Sensory processing disorder

Sensory processing disorder (SPD) is intended to describe patients with symptoms of sensory over-reactivity that do not meet the criteria for autism spectrum disorders (ASD) (Tavassoli T et al, Dev Cog Neurosc 2018;29:72–77). These patients find everyday sensations overwhelming or painful: the tags on clothing, the hum of radiators, or the glare of fluorescent lights. Poor coordination is also common.

SPD has reliable symptoms and a stable course, but it misses the mark on the Feighner criterion of delineation from other disorders. Sensory processing symptoms are often seen in autism, OCD, and ADHD, so SPD is not clearly a disorder in its own right.

Slow cognitive speed

Slow cognitive speed is characterized by a cluster of symptoms that include slow processing, daydreaming, and mental fogginess (it is sometimes called sluggish cognitive tempo). These symptoms are overrepresented in patients with ADHD (Brewe AM et al, Autism 2020;24(6):1373–1383). That said, there is not full agreement on whether slow cognitive speed is a separate diagnosis or if it falls under the umbrella of ADHD.

These symptoms have a particular effect on the patient’s social world, as they tend to make others feel the patient is disinterested or ignoring them. Slow cognitive speed also influences the course of ADHD. Patients with slow cognitive speed tend to have more depression and anxiety, and less disruptive and oppositional behaviors, compared to patients with pure ADHD (Barkley RA. A Review of Research on SCT. In: Barkley RA. Barkley Sluggish Cognitive Tempo Scale—Children and Adolescents (BSCTS-CA). New York, NY: Guilford Press; 2018:3–24). Of psychopharmacological interest is the fact that atomoxetine and lisdexamfetamine (Vyvanse) improve slow cognitive speed independently of their effects on ADHD.

Slow cognitive speed meets a few of Feighner’s diagnostic markers, including a stable clinical description and predictable pharmacologic response, but it may be better thought of as a subtype of ADHD.

“Ring of fire” ADHD

In 1991, psychiatrist Daniel Amen began including SPECT brain scans in routine psychiatric evaluations at his practice in Northern California. The idea has since grown into a database of over 200,000 brain scans across 10 Amen Clinics, but it has not produced any clinical evidence that SPECT scans inform diagnosis or treatment.

Dr. Amen has also proposed seven variants of ADHD: classic, inattentive, overfocused, temporal lobe, limbic, anxious, and “ring of fire.” That last one, also known as “ADHD plus,” has gained particular traction on the internet, although our Medline search did not turn up a single reference.

“Ring of fire” describes a particularly debilitating form of ADHD with prominent externalizing symptoms, such as aggression, overtalkativeness, and mood swings. Those symptoms have led some to suggest that this subtype is on a continuum with bipolar disorder. ADHD and bipolar disorder overlap at a rate that’s greater than expected by chance, but it’s not clear what the “ring” designation adds beyond recognizing the comorbidity.

Complex PTSD

DSM-5 applies the same PTSD classification to very different types of trauma, whether it is sexual abuse from a parent or a bicycle accident as an adult. Complex PTSD aims to bring more specificity to this diagnosis by identifying patients who experienced severe interpersonal traumas that the person cannot escape from, including childhood physical or sexual abuse, domestic violence, torture, genocide, captivity, and slavery.

Complex PTSD has been recognized in ICD-11 since 2018 as code 6B41. The ICD criteria require a trauma of the type described above, along with the three core symptoms of PTSD (re-experience, avoidance, and hyperarousal). In addition, patients must have:

  1. Affective dysregulation, such as emotional reactivity to minor stresses, violent outbursts, reckless or self-destructive behavior, stress-related dissociative symptoms, or emotional numbing.
  2. Persistent negative beliefs about the self. They may see themselves as diminished, defeated, or worthless, and have pervasive feelings of shame, guilt, or failure about the trauma.
  3. Persistent difficulties in sustaining relationships and in feeling close to others. They may avoid relationships or engage in overly intense relationships that they cannot sustain.

The DSM-IV committee left out the disorder because field trials failed to separate it from regular PTSD. Complex PTSD was also rejected from DSM-5, although many of its symptoms were incorporated into the revised criteria for PTSD. The ICD committee based their decision on more recent data that support complex PTSD as a valid and unique disorder.

Specifically, clinician- and patient-rated scales were developed, and they reliably identified a population that was distinct from regular PTSD (one scale is available at www.traumameasuresglobal.com). Studies also suggest that complex PTSD is distinct from borderline personality disorder (BPD). Compared to BPD, patients with complex PTSD have a stable, but negative, identity. They are less impulsive and less likely to engage in self-harm. Laboratory studies also support the diagnosis. Compared to other patients with PTSD, these patients have more extensive structural brain abnormalities and more dysregulation in the areas of the brain involved in emotion regulation. In terms of treatment, some studies suggest they are less likely to respond to traditional psychotherapies for PTSD (Reed GM et al, World Psychiatry 2022;21(2):189–213).

CARLAT VERDICT 

When a patient identifies with a novel diagnosis, approach it with humility and use it as an opportunity to better understand them. After all, many of the DSM-5 disorders don’t meet the strict Feighner criteria for a valid diagnosis, and some of these novel syndromes may prove to be valid diagnoses over time.

General Psychiatry Clinical Update
KEYWORDS ADHD cognition diagnostic criteria dsm PTSD
    Aiken eic 150x150
    Chris Aiken, MD

    Ketamine Assisted Therapy Part I

    More from this author
    Tony Thrasher, DO, DFAPA

    Prior Authorizations for Psychiatric Medications: A Primer for Frustrated Clinicians

    More from this author
    www.thecarlatreport.com
    Issue Date: March 8, 2023
    SUBSCRIBE NOW
    Table Of Contents
    Learning Objectives, Complementary Therapies, TCPR, March 2023
    Deep Rivers Run Quiet. An Update on Social Anxiety Disorder
    Herbal Therapies for Depression
    Four Controversial Diagnoses in Psychiatry: Are They Valid?
    Adjuvant Clonidine for Mania
    CME Post-Test, Complementary Therapies, TCPR, March 2023
    DOWNLOAD NOW
    Featured Book
    • MFB7e_Print_App_Access.png

      Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

      The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2603816031.jpg
      General Psychiatry

      A Scam for Every Woman, Child, and Man: Part 2

      1 in 3 Americans were victims of online scams in the past year. Even when you know your patient is being scammed, it is hard to pull them out. We speak with Cathy Wilson about...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.